| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/27/2004 | US6727411 Method of producing transgenic plants having improved amino acid composition |
| 04/27/2004 | US6727409 Active against lepidoptera |
| 04/27/2004 | US6727408 Polynucleotide which codes protein; for use in generating stress resistant cells |
| 04/27/2004 | US6727407 Shortening flowering time in plants |
| 04/27/2004 | US6727406 Methods for transforming coffee plants to suppress expression of coffee fruit-expressed acc synthase and/or coffee fruit-expressed acc oxidase necessary for ethylene biosynthesis and ripening of coffee fruit |
| 04/27/2004 | US6727405 Transgenic animals secreting desired proteins into milk |
| 04/27/2004 | US6727356 Fluorescent quenching detection reagents and methods |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727350 Toso |
| 04/27/2004 | US6727348 Compositions and methods for the diagnosis and treatment of body weight disorders, including obesity |
| 04/27/2004 | US6727346 Obtaining insulin precursors; generate suspension of insulin and cysteine hydrochloride, heat, recover insulin precursors |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727230 Anti-infective agent, anti- cancer agent, in conjunction with the surgery |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727223 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 04/27/2004 | US6727095 Used to tissue- and time-specifically reduce nitrogen content in storage organ without impairing vital, growth and reproductive functions; for better sugar production |
| 04/27/2004 | US6727092 Methods for the simultaneous detection of HCV antigens and HCV antibodies |
| 04/27/2004 | US6727086 Nucleotide sequences which code for the sigH gene |
| 04/27/2004 | US6727085 Removing egg stains from a hard surface or from laundry, comprising contacting the hard surface or laundry with a composition comprising a subtilase variant which comprises a modification in an amino acid sequence of a subtilase |
| 04/27/2004 | US6727084 Cold-active beta-galactosidase, the process for its preparation and the use thereof |
| 04/27/2004 | US6727083 Protein for use in the generation of bronchodilating agent, pesticides, fungicide, herbicides and for use in the treatment of diabetes |
| 04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
| 04/27/2004 | US6727078 Genetic engineering; removal, insertion gene; lentivirus |
| 04/27/2004 | US6727070 Protein/solubility folding assessed by structural complementation |
| 04/27/2004 | US6727068 Method for non-redundant library construction |
| 04/27/2004 | US6727067 Analysis of target non-proteinaceous components, in particular nucleic acids, using a protease which is relatively cheap, has constant quality and can be used in a variety of processes |
| 04/27/2004 | US6727064 Antiinflammatory agents; anticarcinogenic agents |
| 04/27/2004 | US6727062 Identification of target structures E.G. in vivo selection method for a phage library |
| 04/27/2004 | US6727059 Method for controlling the fidelity and processivity of reverse transcriptase by incorporation and polymerization of nucleotide analogs accepted as substrates for the reverse transcription reaction without blocking its elongation |
| 04/27/2004 | US6727058 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 04/27/2004 | US6726926 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | US6726907 Purified adenoviral compositions |
| 04/27/2004 | US6726883 Spotting pin |
| 04/27/2004 | CA2295999C Nik proteins, nucleic acids and methods |
| 04/27/2004 | CA2177732C Antisense oligonucleotides having tumorigenicity-inhibiting activity |
| 04/27/2004 | CA2152166C Process for detecting fibrocystic desease or a cftr gene mutation |
| 04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
| 04/27/2004 | CA2058370C Monoclonal antibodies against human tumor necrosis factor .alpha. |
| 04/27/2004 | CA1341455C Process for transforming gramineae and the products thereof |
| 04/25/2004 | CA2409897A1 Plasmodium falciparum virulence factor var o |
| 04/24/2004 | WO2004038042A1 A 4-dimensional method and equipment of detecting nucleic acid hybrid pair on the gene chip |
| 04/24/2004 | CA2429101A1 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 04/22/2004 | WO2004034093A2 Caterpiller gene family |
| 04/22/2004 | WO2004034029A2 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/22/2004 | WO2004034013A2 Genotoxicity analysis |
| 04/22/2004 | WO2004033729A1 Method of preserving biological materials |
| 04/22/2004 | WO2004033718A2 Trap-tagging: a novel method for the identification and purification of rna-protein complexes |
| 04/22/2004 | WO2004033715A1 A method for screening for an antimicrobial polypeptide |
| 04/22/2004 | WO2004033708A2 Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration |
| 04/22/2004 | WO2004033707A2 Extraction of dna from biological samples |
| 04/22/2004 | WO2004033696A2 Recombinant adenoviral vectors and applications thereof |
| 04/22/2004 | WO2004033693A1 Methods vectors plasmids and methods for increasing expression of recombinant polypeptides |
| 04/22/2004 | WO2004033692A1 Human prostaglandin g/h synthase 2 splice variant |
| 04/22/2004 | WO2004033690A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 04/22/2004 | WO2004033689A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 04/22/2004 | WO2004033688A1 Cap-binding protein |
| 04/22/2004 | WO2004033687A1 Method of screening remedy for renal failure |
| 04/22/2004 | WO2004033686A1 Novel protein and dna thereof |
| 04/22/2004 | WO2004033685A1 Single chain recombinant t cell receptors |
| 04/22/2004 | WO2004033684A1 A method of altering levels of plasmids |
| 04/22/2004 | WO2004033683A1 Method for enriching a prokaryotic dna |
| 04/22/2004 | WO2004033682A1 Process for producing hyperthermostable endoglucanase |
| 04/22/2004 | WO2004033680A1 Mutagenesis of drug binding region of proteins in methods of drug discovery |
| 04/22/2004 | WO2004033679A1 Decomposition and modification of silicate and silicone by silase and use of the reversible enzyme |
| 04/22/2004 | WO2004033677A2 Secreted acid phosphatase (sapm) is present only in pathogenic mycobacteria and expressed selectively at acidic ph |
| 04/22/2004 | WO2004033675A1 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 04/22/2004 | WO2004033672A2 Stem cell expansion factor blocking a gene limiting hox-induced expansion and method using such factor |
| 04/22/2004 | WO2004033671A1 The microorganism of which the fadr gene was knocked out on the chromosome and a process for producing l-threonine by fermentation with the same mutant |
| 04/22/2004 | WO2004033664A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 04/22/2004 | WO2004033660A2 Gene expression profiling from ffpe samples |
| 04/22/2004 | WO2004033656A2 Gene profiling of single or multiple cells |
| 04/22/2004 | WO2004033653A2 Gene regulation with aptamer and modulator complexes for gene therapy |
| 04/22/2004 | WO2004033646A2 Process for the biological production of 1,3-propanediol with high yield |
| 04/22/2004 | WO2004033640A2 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/22/2004 | WO2004033639A2 Targeting of herpes simplex virus to specific receptors |
| 04/22/2004 | WO2004033636A2 Protein modification and maintenance molecules |
| 04/22/2004 | WO2004033633A2 Compatible host/vector systems for expression of dna |
| 04/22/2004 | WO2004033625A2 Urocortin-deficient mice and uses thereof |
| 04/22/2004 | WO2004033622A2 Preservation of rna and morphology in cells and tissues |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004033618A2 Stabilized naked dna compositions |
| 04/22/2004 | WO2004033614A1 Molecule-releasing apparatus and molecule-releasing method |
| 04/22/2004 | WO2004033498A2 .pharmaceutical composition comprising ht4d100a receptors, and therapeutic uses thereof |
| 04/22/2004 | WO2004033495A2 Regulation of human pde6b |
| 04/22/2004 | WO2004033493A1 Human protein for promoting transformation of 3t3 cell and its coding sequence |
| 04/22/2004 | WO2004033492A1 A brittle-culm-controlling protein and gene encoding it and a method for changing brittleness of plant's stem |
| 04/22/2004 | WO2004033490A2 Hcmv derived immunomodulatory polypeptide |
| 04/22/2004 | WO2004033486A2 Production of homotrimeric fusion proteins |
| 04/22/2004 | WO2004033471A2 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | WO2004033470A2 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 04/22/2004 | WO2004033421A2 Improved production of bacterial strains |
| 04/22/2004 | WO2004033417A2 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 04/22/2004 | WO2004032974A1 Process for generating multilayered particles |
| 04/22/2004 | WO2004032973A2 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032855A2 Method for inhibiting angiogenesis with transforming growth factor-beta 3 inhibitors |
| 04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |